Lanean...
Unilateral Macular Choroidal Neovascularization; a Rare Manifestation in Chronic Myelogenous Leukemia
PURPOSE: To report a case of chronic myelogenous leukemia (CML) treatment with imatinib mesylate in the remission phase who developed unilateral macular choroidal neovascularization (CNV). METHODS: A 45-year-old male marketer with a 5-year history of CML treated with imatinib mesylate presented with...
Gorde:
| Argitaratua izan da: | J Curr Ophthalmol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer - Medknow
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265268/ https://ncbi.nlm.nih.gov/pubmed/32510022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.09.003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|